Atlas Trials

Safety Study of Ch-mAb7F9 for Methamphetamine Abuse

Clinical trial NCT01603147 · COMPLETED

Trial details

NCT number
NCT01603147
Sponsor
InterveXion Therapeutics, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Methamphetamine Abuse
Start date
2012-04-01
Primary completion
2013-07-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.